Trial globalisation drives ClearTrial CTO upgrade
ClearTrial has launched an upgrade to its clinical trial operations (CTO) software, adding more country specific knowledge, such as labour rates, to help companies forecast costs and timelines.
ClearTrial has launched an upgrade to its clinical trial operations (CTO) software, adding more country specific knowledge, such as labour rates, to help companies forecast costs and timelines.
Hikma is to take full control of its Algerian joint venture in an $18.5m (€13.6m) deal, continuing its expansion in the region.
US delivery specialist Penwest is to apply its Timerx tech to “complex” generic pharmaceuticals in a development and commercialisation pact with non-branded drugmaker Alvogen.
DiscoveRx has added GPCR platforms to its portfolio, enhancing its ability to provide information on a compound’s mode of action, activated receptor recycling and efficacy in animal models.
Next week in-Pharmatechnologist heads for the excitement, energy and razamatazz of New York, US and Interphex 2010.
Spain-based Telstar has acquired Usifroid, strengthening its position in France and adding freeze drying technology and expertise.
Sanofi Aventis’ expanded R&D centre in China opened for business last week, further building the French drugmakers presence in the country.